10-Jul-2020 - LGC Ltd.

LGC acquires The Native Antigen Company

Strengthening LGC'S offer to the IVD sector

LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies.

NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a comprehensive portfolio of native and recombinant infectious disease antigens and related products including pathogen receptors, virus-like particles and antibodies for use in immunoassay applications, vaccine development and quality control solutions. NAC was one of the first companies globally to offer antigens for SARS-COV-2 and continues to play an important role in supporting the global response to the COVID-19 pandemic.

The acquisition strengthens LGC’s existing product offering to the IVD sector, which includes a range of quality assurance tools, immunoassay reagents and disease state plasma as well as probes and primers for molecular diagnostics.

Michael Sweatt, Executive Vice President and General Manager, Clinical Diagnostics, LGC, said: “NAC is a natural fit with our clinical diagnostics business and will enable us to provide an expanded portfolio of critical reagents to our customers. NAC’s focus on infectious disease is highly complementary with our existing offer to this segment comprising controls, reference materials, MDx tools and other components. We are excited to welcome our new colleagues into our organisation.”

Facts, background information, dossiers
  • LGC
  • acquisitions
  • Native Antigen Company
More about LGC
  • News

    Cinven and Astorg to acquire LGC

    A consortium jointly led by Astorg and Cinven announced that it has signed an agreement to acquire LGC, a global leader in the Life Sciences Tools sector. Astorg and Cinven identified LGC as an attractive investment opportunity given its: Leading positions in the healthcare, food and agric ... more

    LGC introduces its new LGC Genomics division

    LGC announced the launch of its new LGC Genomics division. Since LGC acquired Berlin-based AGOWA GmbH in 2005, genomics has seen successful growth as part of LGC’s Life & Food Sciences Division. Through AGOWA genomics, LGC has provided an array of flexible nucleic acid sample extraction ser ... more

    LGC's DNA probe technology licensed by Osmetech for rapid genetic testing in molecular diagnostic markets

    LGC's HyBeacons chemistry combines with Osmetech's Genedrive platform to create powerful product offering for hospital testing in-house. LGC, Europe's leading independent analytical laboratory providing advanced chemical, biochemical and forensic analysis, has signed an exclusive agreement ... more

  • Companies

    LGC Ltd.

    LGC is an international life sciences measurement and testing company, building leading positions in sustainably growing markets. Our offering is underpinned by our heritage and expertise in regulation, accreditation and standard setting. We provide reference materials, genomics solutions a ... more

More about Native Antigen